Drug Discovery and Development Analysis & Statistics, December 2014 (p4)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

91-120 of about 1 600 reports

Purchase Reports From Reputable Market Research Publishers

Wheezing Global Clinical Trials Review, H2, 2014

Wheezing Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Wheezing Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Wheezing Global Clinical Trials Review, H2, 2014" provides data on the Wheezing clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Rhinitis Global Clinical Trials Review, H2, 2014

Rhinitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Rhinitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Rhinitis clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Tonsillitis Global Clinical Trials Review, H2, 2014

Tonsillitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Tonsillitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Tonsillitis Global Clinical Trials Review, H2, 2014" provides data on the Tonsillitis clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
Tracheobronchitis Global Clinical Trials Review, H2, 2014

Tracheobronchitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Tracheobronchitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Tracheobronchitis Global Clinical Trials Review, H2, 2014" provides data on the Tracheobronchitis ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Vertigo Global Clinical Trials Review, H2, 2014

Vertigo Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Vertigo Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Vertigo Global Clinical Trials Review, H2, 2014" provides data on the Vertigo clinical trial scenario. This ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Toxoplasmosis Global Clinical Trials Review, H2, 2014

Toxoplasmosis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Toxoplasmosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Toxoplasmosis Global Clinical Trials Review, H2, 2014" provides data on the Toxoplasmosis clinical trial ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Drug and Medication, Pathology
  • Countries : World, United States
Bronchopulmonary Dysplasia - Pipeline Review, H1 2015

Bronchopulmonary Dysplasia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Bronchopulmonary Dysplasia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Bronchopulmonary Dysplasia - Pipeline Review, H1 2015’, provides an overview of the Bronchopulmonary Dysplasia’s ...

  • Industries : Pathology, Pharmaceutical, Research and Development
  • Countries : United States
Women Infertility - Pipeline Review, H1 2015

Women Infertility - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Women Infertility - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2015’, provides an overview of the Women Infertility’s therapeutic pipeline. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States, World
Intermittent Claudication - Pipeline Review, H1 2015

Intermittent Claudication - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Intermittent Claudication - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Intermittent Claudication - Pipeline Review, H1 2015’, provides an overview of the Intermittent Claudication’s ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Hand, Foot And Mouth Disease - Pipeline Review, H1 2015

Hand, Foot And Mouth Disease - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Hand, Foot And Mouth Disease - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H1 2015’, provides an overview of the Hand, Foot And Mouth ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical, Biotechnology
  • Countries : China
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015’, provides an overview of ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Xerostomia - Pipeline Review, H1 2015

Xerostomia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Xerostomia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Xerostomia - Pipeline Review, H1 2015’, provides an overview of the Xerostomia’s therapeutic pipeline. This report provides ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World
Left Ventricular Dysfunction - Pipeline Review, H1 2015

Left Ventricular Dysfunction - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Left Ventricular Dysfunction - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H1 2015’, provides an overview of the Left Ventricular Dysfunction’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Dilated Cardiomyopathy - Pipeline Review, H1 2015

Dilated Cardiomyopathy - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2015’, provides an overview of the Dilated Cardiomyopathy’s therapeutic ...

  • Industries : Pathology
  • Countries : United States
Cholera - Pipeline Review, H1 2015

Cholera - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Cholera - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2015’, provides an overview of the Cholera’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical, Drug and Medication
  • Countries : United States
Tourette Syndrome - Pipeline Review, H1 2015

Tourette Syndrome - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Tourette Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2015’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Nocturia - Pipeline Review, H1 2015

Nocturia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Nocturia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2015’, provides an overview of the Nocturia’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Diabetic Macular Edema - Pipeline Review, H1 2015

Diabetic Macular Edema - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Diabetic Macular Edema - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2015’, provides an overview of the Diabetic Macular Edema’s therapeutic ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Tardive Dyskinesia - Pipeline Review, H1 2015

Tardive Dyskinesia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Tardive Dyskinesia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Tardive Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015’, provides an overview of the Non-Alcoholic St ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015’, provides ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : United States
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014’, ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States, World
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, United States
Portal Hypertension - Pipeline Review, H2 2014

Portal Hypertension - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Portal Hypertension - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Portal Hypertension - Pipeline Review, H2 2014’, provides an overview of the Portal Hypertension’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Tardive Dyskinesia - Pipeline Review, H2 2014

Tardive Dyskinesia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Tardive Dyskinesia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Tardive Dyskinesia - Pipeline Review, H2 2014’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States
Cholestasis - Pipeline Review, H2 2014

Cholestasis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Cholestasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cholestasis - Pipeline Review, H2 2014’, provides an overview of the Cholestasis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
  • Countries : Europe, World
Pulmonary Fibrosis - Pipeline Review, H2 2014

Pulmonary Fibrosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

  • $ 1 495
  • Industry report
  • March 2015
  • by Access China Management Consulting Ltd.

This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which has begun to be implemented on March ...

  • Industries : Drug Discovery and Development
  • Countries : China

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.